COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS

Colorectal cancer (CRC) treatment primarily relies on chemotherapy along with surgery, radiotherapy and, more recently, targeted therapy at the late stages. However, chemotherapeutic drugs have high cytotoxicity, and the similarity between the effects of these drugs on cancerous and healthy cells li...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zheying, Fang, Cheng, Wang, Yongxia, Zhang, Jinghang, Yu, Jian, Zhang, Yongxi, Wang, Xianwei, Zhong, Jiateng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192778/
https://www.ncbi.nlm.nih.gov/pubmed/30132520
http://dx.doi.org/10.3892/ijo.2018.4536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192778/
https://www.ncbi.nlm.nih.gov/pubmed/30132520
http://dx.doi.org/10.3892/ijo.2018.4536

Ejemplares similares